Home Newsfeeds RBC Capital Maintains Outperform on Annaly Capital Management, Raises Price Target to $24

RBC Capital Maintains Outperform on Annaly Capital Management, Raises Price Target to $24

RBC Capital analyst Kenneth Lee maintains Annaly Capital Management (NYSE:NLY) with a Outperform and raises the price target from $20 to $24.

byBenzinga Newsdesk

February 17, 2023

1 minute read

RBC Capital analyst Kenneth Lee maintains Annaly Capital Management (NYSE:NLY) with a Outperform and raises the price target from $20 to $24.

Expedia Group Appoints Julie Whalen As Finance Chief

By Shivani Kumaresan

September 15, 5:57 AM

Expedia Group Inc (NASDAQ:EXPE) has appointed Julie Whalen as the group’s Executive Vice President and Chief Financial Officer, effective September 26,…

EXPE

News

Aerojet Rocketdyne Opens SCEPS Manufacturing Facility For Next Generation Torpedo Propulsion

By Benzinga Newsdesk

August 16, 1:07 PM

Aerojet Rocketdyne has officially opened its Center of Excellence for Undersea Propulsion to support the U.S. Navy's next generation torpedoes. The first of its kind in the nation for industry, the facility will be

AJRD

IGC Pharma Announced Preclinical Trial Data Shows TGR-63 Reduces Plaque in Alzheimer’s

By Charles Gross

January 23, 10:21 AM

IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American: IGC) provides details on its drug candidate TGR-63, which targets amyloid-beta plaque and can potentially improve Alzheimer's disease treatment in a significant manner.

IGC

Clinical Setbacks Prompt NGM Bio Lay Off One Third Of Its Staff, Founder Leaves

By Vandana Singh

April 5, 11:40 AM

NGM Biopharmaceuticals Inc (NASDAQ: NGM) announced will be reducing its workforce by 75 staffers, or a third of the workforce, to extend its cash runway into 2025.

NGM

RBC Capital Maintains Outperform on Annaly Capital Management, Raises Price Target to $24

Related Posts

Expedia Group Appoints Julie Whalen As Finance Chief

Aerojet Rocketdyne Opens SCEPS Manufacturing Facility For Next Generation Torpedo Propulsion

IGC Pharma Announced Preclinical Trial Data Shows TGR-63 Reduces Plaque in Alzheimer’s

Clinical Setbacks Prompt NGM Bio Lay Off One Third Of Its Staff, Founder Leaves